← Open Payments lookup

CASEY SALCEDO: Open Payments

NPI 1699324707 · ROYSTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,547 in 96 payments from 18 companies in 2025. Trend: 2023 $925 · 2024 $1,170 · 2025 $1,547

Food & beverage: $1,547
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$247
ABBVIE INC.17$219
Novo Nordisk Inc13$214
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$138
Axsome Therapeutics, Inc.11$138
AstraZeneca Pharmaceuticals LP4$77
Amgen Inc.4$73
GlaxoSmithKline, LLC.3$70
Lilly USA, LLC4$69
Takeda Pharmaceuticals U.S.A., Inc.3$63

Products named: REXULTI, UBRELVY, CAPLYTA, Auvelity, Ozempic, TRELEGY ELLIPTA, MOUNJARO, TRINTELLIX.

Industry payments across GA — which companies pay providers there.